ASH 2021 Conference Coverage on VuMedi


 

ASH 2021 Efficacy and Safety of Parsaclisib+Ruxolitinib Combination in Patients With Myelofibrosis

13 views
December 22, 2021
Comments 0
Login to view comments. Click here to Login